Contact
Please use this form to send email to PR contact of this press release:
Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024
TO:
Please use this form to send email to PR contact of this press release:
Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024
TO: